Do we Need New Therapies for Diabetes?

Journal Title: Diabetes Research – Open Journal - Year 2015, Vol 1, Issue 3

Abstract

Diabetes research and practice cluster (drug developers, payers, regulators and physicians) often (and especially in recent times) question the need of new therapies. Why would we need new therapies nowadays, when we have 9 classes (insulins, sulfonylureas, biguanides, meglitdes, thiazolidnediones, alpha-glucosidase inhibitors, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists),1 rapidly increasing number of biosimilars2 and uncountable number of generics? Reasonable question. Does it make sense to invest billions of dollars in messy global cardiovascular outcomes trials (as requested by diabetes drug development guidelines3 ) or to play love attraction games with payers4 so they “fall in love” with the “new” pill (most often combo with the good old metformin)?

Authors and Affiliations

Dimiter Dimitrov

Keywords

Related Articles

Rapid Improvement of Blood Glucose Level after Prosthetic Mandibular Advancement in a Patient with Diabetes Mellitus and Obstructive Sleep Apnea

Introduction: Obstructive Sleep Apnea Syndrome (OSAS) is often associated with impaired glucose metabolism. However, the effects of Prosthetic Mandibular Advancement (PMA) on blood glucose levels and insulin resistance r...

Type 1 Diabetic and Hypertensive Retinopathy: Case Presentation and Review of Literature

Background: Type 1 Diabetes (T1D) Mellitus is a complex, chronic illness that affects half a million children under the age of 15 years. Complications associated with diabetic retinopathy can be prevented with continued...

Ocular Health Screening in a Type 1 Diabetes Mellitus Population

Background: Type 1 Diabetes Mellitus is among the most common conditions worldwide, affecting nearly 95 million children worldwide. One of the detrimental effects of this condition can be vision loss. Comprehensive annua...

Basic Ketone Engine and Booster Glucose Engine for Energy Production

Recently, hyperketonemia induced by fasting or ketogenic diet calls attention because of the possibilities for various clinical applications. Animal species comparisons and biochemical data show that all fetuses can deve...

Type 1 Diabetes Update at Children With Diabetes Community

Of the estimated 415 million people living with diabetes worldwide, 10% have Type 1 Diabetes (T1D) meaning they will remain insulin dependent until a cure is found. Globally, we can observe an increasing trend of about 5...

Download PDF file
  • EP ID EP550016
  • DOI 10.17140/DROJ1-112
  • Views 151
  • Downloads 0

How To Cite

Dimiter Dimitrov (2015). Do we Need New Therapies for Diabetes?. Diabetes Research – Open Journal, 1(3), 75-76. https://europub.co.uk/articles/-A-550016